Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients (NCT04948619) | Clinical Trial Compass
RecruitingPhase 2
Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients
United States64 participantsStarted 2022-08-08
Plain-language summary
Pediatric cancer survivors have increased infection-related morbidity and mortality. This study will evaluate immune dysfunction following cancer directed systemic therapy completion, with attention to clinical relevance and infection rate in this population compared to healthy siblings, when applicable. The investigators will also restart vaccinations at earlier time points than previously studied, at 3 months post therapy, and will assess whether boosters or revaccination schedules are superior for regaining immunity against potentially serious infections in survivors.
Who can participate
Age range2 Years – 21 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Written informed consent, HIPAA authorization for release of personal health information, and assent, when applicable from the subject, parent, or legal guardian.
✓. Age greater than or equal to 2 years and less than 22 years at the time of consent
✓. Lansky/Karnofsky Performance Status of greater than 50 (ECOG less than 2) within 30 days prior to date of enrollment
✓. Histological or cytological confirmation of any malignancy treated by the Pediatric Oncology team of Levine Children's Hospital
✓. History of any malignant diagnosis treated with at least one cycle of cancer directed systemic therapy
✓. Must be no more than 60 days from last dose of cancer directed systemic therapy at time of enrollment
✓. As determined by the enrolling physician, ability of the subject and parent/caregiver to understand and comply with study procedures for the entire length of the study
Exclusion criteria
✕. Malignant disease treated with observation, surgery, or radiotherapy alone
What they're measuring
1
Vaccination comparison via objective lab measurements of vaccine titers